News Archives

News Archives

Avivagen Announces Scale Up of Commercial Roll Out for OxC-beta™ Livestock in the Philippines

Ottawa, ON / TNW-Accesswire / August 16, 2017 / – Avivagen Inc. (TSXV:VIV, OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a corporation with a proven and commercially-ready, patent-protected product intended to replace the antibiotics added to livestock feeds as growth promoters, is pleased to announce that its partner in the Philippines, UNAHCO, has confirmed that it …Read More

Cesar Millan To Endorse Avivagen’s Companion Animal Health Product Vivimune Health Chews

Ottawa, ON / July 10, 2017 – Avivagen Inc. (“Avivagen” or the “Corporation” | TSXV: VIV, OTC Pink: CHEXF), a life sciences innovation company with a series of patent protected products that support and optimize health, announces that the Corporation has entered into a marketing agreement with Cesar Millan, world-renowned dog behaviorist, best-selling author, and …Read More

Avivagen Retains Hybrid Financial Inc. for Investor Relations Activities

Ottawa, ON / TNW-Accesswire / July 4, 2017 / – Avivagen Inc. (TSXV:VIV, OTC Pink:CHEXD) (“Avivagen” or the “Corporation”), a corporation with a proven and commercially-ready, patent-protected product intended to replace the antibiotics added to livestock feeds as growth promoters, announces that it has retained the services of Hybrid Financial Inc. for investor relations activities. …Read More

Avivagen Provides Business Updates

  Ottawa, ON / TNW-Accesswire / June 5, 2017 / – Avivagen Inc. (TSXV:VIV, OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a corporation with a proven and commercially-ready, patent-protected product intended to replace the antibiotics added to livestock feeds as growth promoters, announces business updates and an operational update from its Chairman and Interim CEO Kym …Read More

Avivagen Announces Grant Of Stock Options

Ottawa, ON / TNW-Accesswire / May 30, 2017 / – Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a life sciences company commercializing products to replace the antibiotics used in livestock feeds, is accelerating market access and the commercial uptake of its OxC-beta™ Livestock product, an innovative product that has the potential to eliminate the use …Read More

Avivagen Announces Third Purchase Order of OxC-Beta™ Livestock from UNAHCO Inc.

Significant increase in the magnitude of the purchase order Ottawa, ON / TNW-Accesswire / May 26, 2017 / – Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF) (Avivagen or the Corporation), a corporation with a proven and commercially-ready, patent protected product intended to replace the antibiotics added to livestock feeds as growth promoters, announces a third …Read More